InspireMD Announces Pricing of Upsized $18 Million Underwritten Public Offering $NSPR today announced the pricing of an upsized underwritten public offering of securities for gross proceeds of $18 million (or $20.7 million if the underwriters exercise their option to purchase additional securities) prior to deducting underwriting discounts and estimated offering...
Ocugen Inc. Announces $23 Million Registered Direct Offering of Common Stock Priced at a Premium to Market. today announced that it has entered into definitive agreements with healthcare-focused institutional investors for the sale of an aggregate of 3,000,000 shares of its common stock at a purchase price of $7.65 per share in a registered direct offering. The...
Aurora Mobile $JG Partners with Kuaishou to Improve Monetization Efficiency $JG today announced that it has entered into a partnership agreement with Kuaishou Technology (01024.HK) (“Kuaishou”), China’s leading short video content community and social platform, to improve advertising monetization efficiency. By leveraging its powerful artificial intelligence...
$MGNI Magnite to Acquire SpotX Magnite (Nasdaq: MGNI), the largest independent sell-side advertising platform, today announced that it has entered into a definitive agreement to acquire SpotX from RTL Group for $1.17 billion in cash and stock. SpotX is one of the leading platforms shaping CTV and video advertising globally. Deal Creates Largest Independent CTV &...
Tangible catalyst behind surge is due to the upcoming launch of Truforma , Zomedica’s point-of-care (POC) diagnostic device for the detection of thyroid disease in dogs and cats and adrenal disease in dogs. The platform will hit the market on March 30 , and ahead of the product’s debut, the company has also just nabbed a vital distribution deal. Last week,...
$AREC American Resources Corporation Announces Filing of SPAC Registration Statement $AREC Company's SPAC is targeting acquisitions in the land holding and resource industry, and will focus on advancing land and resource assets towards a modern-day business model of clean energy, recycling and redevelopment, and social impact. $AREC today announced that American...
T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis. finance.yahoo.com
Seeking alpha: Sabra Capital Partners places a $7 target on Supercom. Explosive Potential, Limited Downside: We view the base level value of the Company to be $7.00 per share based on a multi-year estimate that revenues will rebound back to $35mm. High conviction. While none of its coronavirus tracking pilots have materialized into a formal, large scale contract,...
Teradata Soars on Strong Earnings and Demand for Cloud Shares soared Friday after the data-analytics company reported stronger-than-expected fourth-quarter earnings (triple-digit cloud growth), benefiting from corporate demand for enterprise software and cloud services. Annual recurring revenue (ARR) increased 11% from the prior year period(1) Public cloud ARR...
Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of COVAXIN™ in the US Market. Definitive Agreement provides details of the previously announced intent to co-develop COVAXIN™ for the US market. Ocugen and Bharat Biotech to share US commercialization profits. Ocugen to receive initial supply of COVAXIN™ doses from...
Why ATA Creativity Skyrocketed 951% yesterday There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media. ATA shares were buoyed — thanks to discussions stock trading groups on Facebook, Discord chat rooms, the r/Daytrading subreddit, Twitter hashtags, and YouTube channels...
Why LAIX Stock Price Increased Over 100% in Pre-Market LAIX is an AI company that provides online English learning products and services in China. Since the company has not announced any news directly and there are no SEC reports to trigger a stock price increase, it appears there was a coordinated move on social media to drive the price up, similar to the...
JUST GOT POSITIVE EU RECOMMENDATION $AIM (old $HEB) granted EU Orphan Drug Designation for Rintatolimod for treatment of pancreatic cancer, Hemispherx Biopharma Europe. Rintatolimod is Ampligen This is going to trap shorts and when they PR this is going to explode! www.ema.europa.eu
23andMe to Merge with Virgin Group's VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics. - 23andMe is a leading consumer genetics and research company that offers a personalized health and wellness experience, and has built a premier genetic database to unlock...
REE Automotive to List on NASDAQ Through Merger with 10X Capital Venture Acquisition Corp REE’s fully-flat and modular EV platforms are based on proprietary REEcorner technology, positioned to become the cornerstone of next-generation e-Mobility. The transaction is expected to provide more than $500 million of gross proceeds to the Company. This includes funds...
Sympathy play Anavex stock gained after favorable data from Cassava Sciences in Alzheimer’s! With a rise yesterday, Cassava Sciences extended its gains after announcement of favorable data from an open-label study in Alzheimer’s disease! The shares have been on a bullish mode for the last several days, reaching an all-time high, on encouraging data for its...
“Strong Buy” Penny Stock With Over 200% Upside on the Horizon a biotechnology company with a focus on the treatment of glioblastomas, a class of aggressive tumors that attack the braid and spinal cord. These cancers, while rare, are almost always terminal, and CNS is working a new therapy designed to more effectively cross the blood-brain barrier to attack...
Alziehmer play with good vol and Feb 9 Catalyst milestones for Q1/Q2 1. First Patient In (FPI) for Phase III (Study 301) 2. Top Line results for completed Phase I/II (Study 201) 3. Commercial Scale Manufacturing Batch Pre-IND Meeting Request for AD